Back To: Home : Featured Technology : High Throughput Screening

CLICK HERE FOR WHAT'S NEW IN:
 

PPARalpha, PPARdelta and LXRalpha assay systems
January 2010
SHARING OPTIONS:

INDIGO Biosciences
 
Researchers seeking an off-the-shelf solution for screening of activity against human peroxisome proliferator-activated receptor alpha and delta (also known as beta) as well as Liver X receptor alpha, members of the family of human nuclear receptors, now have assay systems that are ready to use when they are ready to test. INDIGO Biosciences has introduced the human PPARa, PPARd and LXRa Assay Systems, the newest additions to its portfolio of cell-based, nuclear receptor reporter assay products for on-demand use in drug discovery and development. INDIGO Biosciences' assays enable sensitive screening of test compounds for agonist or antagonist activities for use in primary screening or secondary and toxicology screening. The all-inclusive assay systems feature high signal-to-noise ratios, and excellent Z' scores. The company's proprietary cryopreservation process, CryoMite, permits overnight delivery for on-demand use. Kits are optimally configured for high- or low-throughput screening in 3x 32-, 96- and 384-well plate formats.
 
INDIGO Biosciences
(814) 234-1919
www.indigobiosciences.com 
   

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.